This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 102/6/633    most recent CIRCRESAHA.107.165183v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gourine, A. Articles by Gourine, A. V. Search for Related Content PubMed PubMed Citation Articles by Gourine, A. Articles by Gourine, A. V. Related Collections Cardio-renal physiology/pathophysiology Animal models of human disease Heart failure - basic studies Autonomic, reflex, and neurohumoral control of circulation

(Circulation Research. 2008;102:633.)
© 2008 American Heart Association, Inc.

Report

Beneficial Effect of the Central Nervous System β-Adrenoceptor Blockade on the Failing Heart

Andrey Gourine, Svetlana I. Bondar, K. Michael Spyer, Alexander V. Gourine

From the Department of Physiology, University College London, United Kingdom.

Correspondence to Alexander V. Gourine, PhD, Department of Physiology, University College London, Gower St, London WC1E 6BT, United Kingdom. E-mail a.gourine{at}ucl.ac.uk

Heart failure patients are routinely given β-adrenoceptor antagonists (β-blockers), although the mechanism(s) underlying their beneficial effects is not fully resolved. It is not entirely clear how long-term application of negative inotropic compounds improves cardiac performance, slows remodeling processes, and decreases mortality. All β-blockers, which produce a beneficial effect in heart failure, have in common a high degree of lipophilicity and, therefore, have the ability to cross the blood–brain barrier. Here, we show that blockade of β-adrenoceptors directly in the brain (chronic intracerebroventricular administration of metoprolol) attenuates the progression of left ventricular remodeling in a rat model of myocardial infarction-induced heart failure. These results provide the first direct evidence that the action of certain β-blockers in the brain could contribute to their beneficial effect on the failing heart.

Key Words: central nervous system • β-blockers • heart failure • left ventricular remodeling • myocardial infarction

This article has been cited by other articles:

				R. Aguilar-Torres Found in translation: metoprolol improves survival more than carvedilol in a mouse model of inherited dilated cardiomyopathy Cardiovasc Res, October 1, 2009; 84(1): 7 - 8. [Full Text] [PDF]

				D.-Y. Zhan, S. Morimoto, C.-K. Du, Y.-Y. Wang, Q.-W. Lu, A. Tanaka, T. Ide, Y. Miwa, F. Takahashi-Yanaga, and T. Sasaguri Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation Cardiovasc Res, October 1, 2009; 84(1): 64 - 71. [Abstract] [Full Text] [PDF]

				M. Pu, Z. Gao, X. Zhang, D. Liao, D. K. Pu, T. Brennan, and W. R. Davidson Jr. Impact of mitral regurgitation on left ventricular anatomic and molecular remodeling and systolic function: implication for outcome Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1727 - H1732. [Abstract] [Full Text] [PDF]

				M. T. La Rovere, G. D. Pinna, R. Maestri, E. Robbi, A. Caporotondi, G. Guazzotti, P. Sleight, and O. Febo Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J. Am. Coll. Cardiol., January 13, 2009; 53(2): 193 - 199. [Abstract] [Full Text] [PDF]